AstraZeneca wins US approval for lymphoma drug

ABC News -

ABC News—U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma. The Food and Drug Administration on Tuesday granted accelerated approval to AstraZeneca PLC for its Calquence (KAL'-kwens) for treating patients after chemotherapy or other treatments fail....

AstraZeneca wins US approval for lymphoma drug. U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma....